Kcl + Glucose, Viaflo Baxter (Potassium Chloride, Glucose)

Potassium chloride dissociates after injection, releasing potassium ions that are essential for maintaining normal cell membrane potential, nerve impulse transmission, and cardiac rhythm. The added glucose is quickly metabolized, raising plasma glucose and stimulating insulin release, which helps shift potassium into cells, supporting overall electrolyte balance.

The dose of Kcl + Glucose is determined by the prescribing clinician based on the patient’s serum potassium, blood glucose level, renal function, and overall clinical condition. Healthcare professionals calculate the appropriate volume and rate of infusion to safely correct electrolyte and glucose abnormalities.

Safety data for Kcl + Glucose in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it must be prescribed and monitored by a qualified healthcare provider.

To order Kcl + Glucose, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain handling if required) and any necessary import documentation.

Kcl + Glucose combines potassium chloride with glucose, offering simultaneous electrolyte correction and carbohydrate support. Compared with potassium chloride alone, the added glucose can help prevent hypoglycemia and may facilitate intracellular potassium shift. Alternative products may provide potassium without glucose, requiring separate glucose administration if needed.

Kcl + Glucose should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Do not use the product if it has been exposed to temperatures outside the recommended range.

The solution is administered intravenously by slow infusion, typically through a peripheral or central venous line. The infusion rate is set by the prescriber based on the patient’s electrolyte and glucose needs, and the administration should be performed by qualified healthcare personnel in a clinical setting.

The most serious risks include severe hyperkalemia, which can cause life‑threatening cardiac arrhythmias, and acute hyperglycemia, which may lead to osmotic diuresis and metabolic complications. Anaphylactic reactions, although rare, are also a critical concern and require immediate medical attention.

Kcl + Glucose should be avoided in patients with known hyperkalemia, severe renal impairment, or those who are allergic to any component of the formulation. It should also be used with caution in patients with uncontrolled diabetes, as the glucose component may exacerbate hyperglycemia.